Role of urothelial cells in BCG immunotherapy for superficial bladder cancer

Intravesical instillation of Bacillus Calmette-Guérin (BCG) is used for the treatment of superficial bladder cancer, both to reduce the recurrence rate of bladder tumour and to diminish the risk of progression. Since its first therapeutic application in 1976, major research efforts have been directe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bevers, R F M, Kurth, K-H, Schamhart, D H J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364784/
https://www.ncbi.nlm.nih.gov/pubmed/15266312
http://dx.doi.org/10.1038/sj.bjc.6602026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364784/
https://www.ncbi.nlm.nih.gov/pubmed/15266312
http://dx.doi.org/10.1038/sj.bjc.6602026

Ejemplares similares